Jazz Pharmaceuticals plc’s filing revealed that its Director O’Keefe Kenneth W acquired Company’s shares for reported $0.22 million on Dec 02 ’25. In the deal valued at $176.59 per share,1,249 shares were bought.
Then, COZADD BRUCE C sold 77,500 shares, generating $13,780,337 in total proceeds. Upon selling the shares at $177.81, the Director now owns 393,332 shares.
Before that, BRUCE COZADD bought 77,500 shares. Jazz Pharmaceuticals plc shares valued at $13,780,337 were divested by the Director at a price of $177.81 per share.
UBS downgraded its Jazz Pharmaceuticals plc [JAZZ] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who began to cover the stock in mid July with a ‘”a Buy”‘ rating. UBS also remained covering JAZZ and has increased its forecast on March 07, 2025 with a “Buy” recommendation from previously “Neutral” rating. Cantor Fitzgerald revised its rating on February 26, 2025. It rated JAZZ as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of JAZZ
On Tuesday, Jazz Pharmaceuticals plc [NASDAQ:JAZZ] saw its stock fall -3.14% to $166.71. Over the last five days, the stock has lost -7.84%. Jazz Pharmaceuticals plc shares have risen nearly 35.93% since the year began. Nevertheless, the stocks have risen 35.37% over the past one year. While a 52-week high of $182.99 was reached on 11/18/25, a 52-week low of $95.49 was recorded on 04/09/25.
Levels Of Support And Resistance For JAZZ Stock
The 24-hour chart illustrates a support level at 164.30, which if violated will result in even more drops to 161.89. On the upside, there is a resistance level at 171.36. A further resistance level may holdings at 176.01.
How much short interest is there in Jazz Pharmaceuticals plc?
A steep rise in short interest was recorded in Jazz Pharmaceuticals plc stocks on 2025-11-14, growing by 0.15 million shares to a total of 4.84 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 4.69 million shares. There was a rise of 3.1%, which implies that there is a positive sentiment for the stock.
